Risk prediction of esophageal squamous cell carcinoma recurrence in patients who underwent esophagectomy after receiving neoadjuvant treatment: a nationwide retrospective study in Japan
ConclusionsThe model developed in this study adequately predicted ESCC recurrence in patients who underwent NAT and then esophagectomy. Further research with this nomogram is needed to assess the effect of adjuvant therapy in patients at high risk for recurrence.
Source: Esophagus - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Esophagectomy | Esophagus Cancer | Gastroenterology | Japan Health | Neoadjuvant Therapy | Skin Cancer | Squamous Cell Carcinoma | Study